Francine M Jodelka Selected Research

Deafness (Deaf Mutism)

1/2020	Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction.
1/2017	Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c.
3/2013	Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francine M Jodelka Research Topics

Disease

3	Deafness (Deaf Mutism) 01/2020 - 03/2013
3	type 1C Usher syndrome 01/2020 - 01/2017
2	Usher Syndromes (Usher Syndrome) 01/2017 - 03/2013
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2014 - 11/2009
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Blindness (Hysterical Blindness) 03/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2009
1	Parkinsonian Disorders (Parkinsonism) 11/2007
1	Neoplasms (Cancer) 05/2006

Drug/Important Bio-Agent (IBA)

5	Antisense OligonucleotidesIBA 01/2020 - 03/2013
2	RNA Precursors (Precursor, mRNA)IBA 01/2020 - 03/2013
2	Protein Isoforms (Isoforms)IBA 01/2016 - 11/2007
1	Mifepristone (RU 486)FDA Link 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	TetracyclinesIBA 11/2009
1	DNA (Deoxyribonucleic Acid)IBA 05/2006
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2006

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2009
1	Biological Therapy 01/2017